secwatch.observer — SEC 8-K summary
======================================

Issuer:     Acurx Pharmaceuticals, Inc. (ACXP)
CIK:        0001736243
Form:       8-K
Filed at:   2024-06-17T23:59:59+00:00
Accession:  0001104659-24-072270
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Acurx Pharmaceuticals announces results of annual shareholder meeting; directors elected, auditor ratified
--------------------------------------------------------------------------------

- Quorum of 67.29% of outstanding shares (10,648,350 of 15,823,102) was present at June 17, 2024 Annual Meeting.
- Class III directors Robert J. DeLuccia, Joseph C. Scodari, James Donohue re-elected with broker non-votes of 4,836,213 each.
- Ratification of CohnReznick LLP as independent auditor for FY2024 passed with 10,542,955 votes for, 69,261 against, 36,134 abstentions.
- All director nominees received majority of votes cast excluding broker non-votes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1736243/000110465924072270/0001104659-24-072270-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1736243/000110465924072270/tm2417425d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-072270

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer